Evidence check: Testosteron Test in the context of Langlebigkeit

A testosterone test in the context of longevity has limited scientific value when used in isolation. Testosterone levels fluctuate diurnally, vary with age, and are influenced by lifestyle, stress, and comorbidities. A single measurement does not reliably predict biological aging or lifespan. Free testosterone (not bound to SHBG) is more clinically relevant, but even its association with longevity is weak and inconsistent across studies. In men, low testosterone is linked to metabolic syndrome and frailty, but causality remains uncertain. In women, the role of testosterone is even less clear. Genetic tests for testosterone-related SNPs (e.g., SHBG) indicate only predisposition, not current levels. For longevity assessment, a multi-marker panel (e.g., HbA1c, CRP, vitamin D, telomere length) combined with clinical evaluation is far more informative. Evidence grade: human-observational, mechanistic. Caveat: No single test can diagnose or predict longevity; always interpret in clinical context.